![](/img/cover-not-exists.png)
Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models
Lehmann, Christian, Friess, Thomas, Birzele, Fabian, Kiialainen, Anna, Dangl, MarkusVolume:
9
Language:
english
Journal:
Journal of Hematology & Oncology
DOI:
10.1186/s13045-016-0280-3
Date:
December, 2016
File:
PDF, 1.13 MB
english, 2016